DGKA
Appearance
Diacylglycerol kinase alpha is an enzyme that in humans is encoded by the DGKA gene.[5][6][7]
The protein encoded by this gene belongs to the eukaryotic diacylglycerol kinase family. It acts as a modulator that competes with protein kinase C for the second messenger diacylglycerol in intracellular signaling pathways. It also plays an important role in the resynthesis of phosphatidylinositols and phosphorylating diacylglycerol to phosphatidic acid. Alternative splicing occurs at this locus and four transcript variants encoding the same protein have been identified.[7]
References
[edit]- 1 2 3 GRCh38: Ensembl release 89: ENSG00000065357 – Ensembl, May 2017
- 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000025357 – Ensembl, May 2017
- ↑ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ↑ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ↑ Hart TC, Champagne C, Zhou J, Van Dyke TE (June 1994). "Assignment of the gene for diacylglycerol kinase (DAGK) to human chromosome 12". Mammalian Genome. 5 (2): 123–124. doi:10.1007/BF00292343. PMID 8180475. S2CID 305119.
- ↑ Hart TC, Zhou J, Champagne C, Van Dyke TE, Rao PN, Pettenati MJ (December 1994). "Assignment of the human diacylglycerol kinase gene (DAGK) to 12q13.3 using fluorescence in situ hybridization analysis". Genomics. 22 (1): 246–247. doi:10.1006/geno.1994.1376. PMID 7959783.
- 1 2 "Entrez Gene: DGKA diacylglycerol kinase, alpha 80kDa".
Further reading
[edit]- Kovalenko A, Sanin A, Kosmas K, Zhang L, Wang J, Akl EW, et al. (April 2021). "Therapeutic Targeting of DGKA-Mediated Macropinocytosis Leads to Phospholipid Reprogramming in Tuberous Sclerosis Complex". Cancer Research. 81 (8): 2086–2100. doi:10.1158/0008-5472.CAN-20-2218. PMC 8137542. PMID 33593821.
- Topham MK, Prescott SM (1999). "Mammalian diacylglycerol kinases, a family of lipid kinases with signaling functions". The Journal of Biological Chemistry. 274 (17): 11447–11450. doi:10.1074/jbc.274.17.11447. PMID 10206945.
- Schaap D, de Widt J, van der Wal J, Vandekerckhove J, van Damme J, Gussow D, et al. (November 1990). "Purification, cDNA-cloning and expression of human diacylglycerol kinase". FEBS Letters. 275 (1–2): 151–158. doi:10.1016/0014-5793(90)81461-V. PMID 2175712. S2CID 45452518.
- Flores I, Casaseca T, Martinez-A C, Kanoh H, Merida I (April 1996). "Phosphatidic acid generation through interleukin 2 (IL-2)-induced alpha-diacylglycerol kinase activation is an essential step in IL-2-mediated lymphocyte proliferation". The Journal of Biological Chemistry. 271 (17): 10334–10340. doi:10.1074/jbc.271.17.10334. hdl:10261/378836. PMID 8626603.
- Jones DR, Pettitt TR, Sanjuán MA, Mérida I, Wakelam MJ (June 1999). "Interleukin-2 causes an increase in saturated/monounsaturated phosphatidic acid derived from 1,2-diacylglycerol and 1-O-alkyl-2-acylglycerol". The Journal of Biological Chemistry. 274 (24): 16846–16852. doi:10.1074/jbc.274.24.16846. PMID 10358029.
- Sanjuán MA, Jones DR, Izquierdo M, Mérida I (2001). "Role of Diacylglycerol Kinase α in the Attenuation of Receptor Signaling". The Journal of Cell Biology. 153 (1): 207–220. doi:10.1083/jcb.153.1.207. PMC 2185527. PMID 11285286.
- Sanjuán MA, Pradet-Balade B, Jones DR, Martínez-A C, Stone JC, Garcia-Sanz JA, et al. (March 2003). "T cell activation in vivo targets diacylglycerol kinase alpha to the membrane: a novel mechanism for Ras attenuation". Journal of Immunology. 170 (6). Baltimore: 2877–2883. doi:10.4049/jimmunol.170.6.2877. PMID 12626538.
- Li J, Hawkins IC, Harvey CD, Jennings JL, Link AJ, Patton JG (November 2003). "Regulation of alternative splicing by SRrp86 and its interacting proteins". Molecular and Cellular Biology. 23 (21): 7437–7447. doi:10.1128/MCB.23.21.7437-7447.2003. PMC 207616. PMID 14559993.
- Gronert K, Kantarci A, Levy BD, Clish CB, Odparlik S, Hasturk H, et al. (February 2004). "A molecular defect in intracellular lipid signaling in human neutrophils in localized aggressive periodontal tissue damage". Journal of Immunology. 172 (3). Baltimore: 1856–1861. doi:10.4049/jimmunol.172.3.1856. PMC 4318492. PMID 14734770.
- Verrier E, Wang L, Wadham C, Albanese N, Hahn C, Gamble JR, et al. (June 2004). "PPARgamma agonists ameliorate endothelial cell activation via inhibition of diacylglycerol-protein kinase C signaling pathway: role of diacylglycerol kinase". Circulation Research. 94 (11): 1515–1522. doi:10.1161/01.RES.0000130527.92537.06. PMID 15117825. S2CID 25057646.
- Baldanzi G, Mitola S, Cutrupi S, Filigheddu N, van Blitterswijk WJ, Sinigaglia F, et al. (June 2004). "Activation of diacylglycerol kinase alpha is required for VEGF-induced angiogenic signaling in vitro". Oncogene. 23 (28): 4828–4838. doi:10.1038/sj.onc.1207633. hdl:11379/21460. PMID 15122338.
- Alonso R, Rodríguez MC, Pindado J, Merino E, Mérida I, Izquierdo M (August 2005). "Diacylglycerol kinase alpha regulates the secretion of lethal exosomes bearing Fas ligand during activation-induced cell death of T lymphocytes". The Journal of Biological Chemistry. 280 (31): 28439–28450. doi:10.1074/jbc.M501112200. hdl:10261/158459. PMID 15870081.
- Bacchiocchi R, Baldanzi G, Carbonari D, Capomagi C, Colombo E, van Blitterswijk WJ, et al. (September 2005). "Activation of alpha-diacylglycerol kinase is critical for the mitogenic properties of anaplastic lymphoma kinase". Blood. 106 (6): 2175–2182. doi:10.1182/blood-2005-01-0316. PMID 15928040.
- Yanagisawa K, Yasuda S, Kai M, Imai S, Yamada K, Yamashita T, et al. (April 2007). "Diacylglycerol kinase alpha suppresses tumor necrosis factor-alpha-induced apoptosis of human melanoma cells through NF-kappaB activation". Biochimica et Biophysica Acta. 1771 (4): 462–474. doi:10.1016/j.bbalip.2006.12.008. PMID 17276726.